The eRulemaking Program

04/02/2024 | Press release | Distributed by Public on 04/02/2024 07:32

Electronic Submission of Expedited Safety Reports From Investigational New Drug-Exempt Bioavailability/ Bioequivalence Studies; Guidance for Industry; Availability

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.